nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—SLC22A7—Rifampicin—leprosy	0.729	1	CbGbCtD
Allopurinol—Infertility male—Dapsone—leprosy	0.0271	0.0998	CcSEcCtD
Allopurinol—Retinitis—Thalidomide—leprosy	0.0152	0.0561	CcSEcCtD
Allopurinol—Footdrop—Thalidomide—leprosy	0.0139	0.0511	CcSEcCtD
Allopurinol—Peroneal nerve palsy—Thalidomide—leprosy	0.0118	0.0435	CcSEcCtD
Allopurinol—Mental status changes—Thalidomide—leprosy	0.00679	0.025	CcSEcCtD
Allopurinol—Status epilepticus—Thalidomide—leprosy	0.00679	0.025	CcSEcCtD
Allopurinol—Swelling face—Dapsone—leprosy	0.00656	0.0242	CcSEcCtD
Allopurinol—Tumour lysis syndrome—Thalidomide—leprosy	0.00576	0.0212	CcSEcCtD
Allopurinol—Septic shock—Thalidomide—leprosy	0.0053	0.0195	CcSEcCtD
Allopurinol—Albuminuria—Dapsone—leprosy	0.00418	0.0154	CcSEcCtD
Allopurinol—Electrolyte imbalance—Thalidomide—leprosy	0.00383	0.0141	CcSEcCtD
Allopurinol—Pericarditis—Thalidomide—leprosy	0.0037	0.0136	CcSEcCtD
Allopurinol—Peripheral vascular disorder—Thalidomide—leprosy	0.00326	0.012	CcSEcCtD
Allopurinol—Skin exfoliation—Dapsone—leprosy	0.00298	0.011	CcSEcCtD
Allopurinol—Foetor hepaticus—Thalidomide—leprosy	0.00282	0.0104	CcSEcCtD
Allopurinol—Enlargement abdomen—Thalidomide—leprosy	0.00266	0.00979	CcSEcCtD
Allopurinol—Hypomagnesaemia—Thalidomide—leprosy	0.00252	0.00927	CcSEcCtD
Allopurinol—Liver disorder—Thalidomide—leprosy	0.00235	0.00864	CcSEcCtD
Allopurinol—Intestinal obstruction—Thalidomide—leprosy	0.00235	0.00864	CcSEcCtD
Allopurinol—Hypercalcaemia—Thalidomide—leprosy	0.0023	0.00848	CcSEcCtD
Allopurinol—Hepatomegaly—Thalidomide—leprosy	0.00226	0.00832	CcSEcCtD
Allopurinol—Hyperlipidaemia—Thalidomide—leprosy	0.00222	0.00817	CcSEcCtD
Allopurinol—Albuminuria—Thalidomide—leprosy	0.00214	0.00789	CcSEcCtD
Allopurinol—Neuritis—Thalidomide—leprosy	0.00214	0.00789	CcSEcCtD
Allopurinol—Amblyopia—Thalidomide—leprosy	0.00207	0.00763	CcSEcCtD
Allopurinol—Tingling sensation—Thalidomide—leprosy	0.00199	0.00733	CcSEcCtD
Allopurinol—Numbness—Thalidomide—leprosy	0.00193	0.0071	CcSEcCtD
Allopurinol—Apnoea—Thalidomide—leprosy	0.00189	0.00695	CcSEcCtD
Allopurinol—Sensory loss—Thalidomide—leprosy	0.00185	0.0068	CcSEcCtD
Allopurinol—Vasodilation—Thalidomide—leprosy	0.00182	0.0067	CcSEcCtD
Allopurinol—Jaundice cholestatic—Thalidomide—leprosy	0.00182	0.0067	CcSEcCtD
Allopurinol—Vasodilation procedure—Thalidomide—leprosy	0.00182	0.0067	CcSEcCtD
Allopurinol—Hyperbilirubinaemia—Thalidomide—leprosy	0.00176	0.00648	CcSEcCtD
Allopurinol—Cellulitis—Thalidomide—leprosy	0.00176	0.00648	CcSEcCtD
Allopurinol—Hypocalcaemia—Thalidomide—leprosy	0.00175	0.00643	CcSEcCtD
Allopurinol—Oliguria—Thalidomide—leprosy	0.00174	0.00639	CcSEcCtD
Allopurinol—Neuropathy peripheral—Dapsone—leprosy	0.00171	0.00631	CcSEcCtD
Allopurinol—Leukocytosis—Thalidomide—leprosy	0.0017	0.00627	CcSEcCtD
Allopurinol—Creatinine increased—Thalidomide—leprosy	0.00168	0.00619	CcSEcCtD
Allopurinol—Pulmonary embolism—Thalidomide—leprosy	0.0016	0.00589	CcSEcCtD
Allopurinol—Hepatocellular injury—Thalidomide—leprosy	0.0016	0.00589	CcSEcCtD
Allopurinol—Hyperkalaemia—Thalidomide—leprosy	0.00157	0.00579	CcSEcCtD
Allopurinol—Pharyngitis—Dapsone—leprosy	0.00156	0.00573	CcSEcCtD
Allopurinol—Skin exfoliation—Thalidomide—leprosy	0.00153	0.00562	CcSEcCtD
Allopurinol—Neuropathy—Thalidomide—leprosy	0.0015	0.00553	CcSEcCtD
Allopurinol—Aplastic anaemia—Thalidomide—leprosy	0.0015	0.00553	CcSEcCtD
Allopurinol—Tinnitus—Dapsone—leprosy	0.00146	0.00539	CcSEcCtD
Allopurinol—Rash maculo-papular—Thalidomide—leprosy	0.00145	0.00535	CcSEcCtD
Allopurinol—Gynaecomastia—Thalidomide—leprosy	0.00143	0.00527	CcSEcCtD
Allopurinol—Sepsis—Thalidomide—leprosy	0.00139	0.00511	CcSEcCtD
Allopurinol—Lymphadenopathy—Thalidomide—leprosy	0.00136	0.00501	CcSEcCtD
Allopurinol—Thrombophlebitis—Thalidomide—leprosy	0.00134	0.00494	CcSEcCtD
Allopurinol—Diabetes mellitus—Thalidomide—leprosy	0.00133	0.00492	CcSEcCtD
Allopurinol—Vascular purpura—Thalidomide—leprosy	0.0013	0.00478	CcSEcCtD
Allopurinol—Eczema—Thalidomide—leprosy	0.00129	0.00476	CcSEcCtD
Allopurinol—Renal failure acute—Thalidomide—leprosy	0.00126	0.00463	CcSEcCtD
Allopurinol—Amnesia—Thalidomide—leprosy	0.00124	0.00455	CcSEcCtD
Allopurinol—Dermatitis exfoliative—Thalidomide—leprosy	0.00123	0.00453	CcSEcCtD
Allopurinol—Vertigo—Dapsone—leprosy	0.00123	0.00452	CcSEcCtD
Allopurinol—Dermatitis bullous—Thalidomide—leprosy	0.00121	0.00447	CcSEcCtD
Allopurinol—Purpura—Thalidomide—leprosy	0.0012	0.00444	CcSEcCtD
Allopurinol—Cardiac failure—Thalidomide—leprosy	0.00119	0.00438	CcSEcCtD
Allopurinol—Cerebrovascular accident—Thalidomide—leprosy	0.00118	0.00436	CcSEcCtD
Allopurinol—Hyponatraemia—Thalidomide—leprosy	0.00117	0.00429	CcSEcCtD
Allopurinol—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00116	0.00428	CcSEcCtD
Allopurinol—Face oedema—Thalidomide—leprosy	0.00112	0.00413	CcSEcCtD
Allopurinol—Ataxia—Thalidomide—leprosy	0.00109	0.00402	CcSEcCtD
Allopurinol—Blood creatinine increased—Thalidomide—leprosy	0.00109	0.00401	CcSEcCtD
Allopurinol—Hypokalaemia—Thalidomide—leprosy	0.00106	0.00389	CcSEcCtD
Allopurinol—Breast disorder—Thalidomide—leprosy	0.00105	0.00386	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00105	0.00385	CcSEcCtD
Allopurinol—Abdominal distension—Thalidomide—leprosy	0.00101	0.00372	CcSEcCtD
Allopurinol—Insomnia—Dapsone—leprosy	0.00101	0.00371	CcSEcCtD
Allopurinol—Eosinophilia—Thalidomide—leprosy	0.000993	0.00366	CcSEcCtD
Allopurinol—Bronchospasm—Thalidomide—leprosy	0.000987	0.00363	CcSEcCtD
Allopurinol—Angina pectoris—Thalidomide—leprosy	0.000977	0.0036	CcSEcCtD
Allopurinol—Pancytopenia—Thalidomide—leprosy	0.000953	0.00351	CcSEcCtD
Allopurinol—Neutropenia—Thalidomide—leprosy	0.000938	0.00346	CcSEcCtD
Allopurinol—Erectile dysfunction—Thalidomide—leprosy	0.000924	0.0034	CcSEcCtD
Allopurinol—Weight increased—Thalidomide—leprosy	0.000913	0.00336	CcSEcCtD
Allopurinol—Gastrointestinal pain—Dapsone—leprosy	0.000911	0.00336	CcSEcCtD
Allopurinol—Hyperglycaemia—Thalidomide—leprosy	0.000905	0.00333	CcSEcCtD
Allopurinol—Drowsiness—Thalidomide—leprosy	0.000894	0.00329	CcSEcCtD
Allopurinol—Depression—Thalidomide—leprosy	0.000892	0.00329	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000887	0.00327	CcSEcCtD
Allopurinol—Abdominal pain—Dapsone—leprosy	0.000881	0.00324	CcSEcCtD
Allopurinol—Body temperature increased—Dapsone—leprosy	0.000881	0.00324	CcSEcCtD
Allopurinol—Neuropathy peripheral—Thalidomide—leprosy	0.000877	0.00323	CcSEcCtD
Allopurinol—Stomatitis—Thalidomide—leprosy	0.000872	0.00321	CcSEcCtD
Allopurinol—Conjunctivitis—Thalidomide—leprosy	0.000869	0.0032	CcSEcCtD
Allopurinol—Sweating—Thalidomide—leprosy	0.000858	0.00316	CcSEcCtD
Allopurinol—Haematuria—Thalidomide—leprosy	0.000853	0.00314	CcSEcCtD
Allopurinol—Epistaxis—Thalidomide—leprosy	0.000844	0.00311	CcSEcCtD
Allopurinol—Agranulocytosis—Thalidomide—leprosy	0.000835	0.00307	CcSEcCtD
Allopurinol—Bradycardia—Thalidomide—leprosy	0.000817	0.00301	CcSEcCtD
Allopurinol—Rhinitis—Thalidomide—leprosy	0.000805	0.00297	CcSEcCtD
Allopurinol—Hepatitis—Thalidomide—leprosy	0.000803	0.00296	CcSEcCtD
Allopurinol—Hypoaesthesia—Thalidomide—leprosy	0.000799	0.00294	CcSEcCtD
Allopurinol—Pharyngitis—Thalidomide—leprosy	0.000797	0.00294	CcSEcCtD
Allopurinol—Urinary tract disorder—Thalidomide—leprosy	0.000793	0.00292	CcSEcCtD
Allopurinol—Urethral disorder—Thalidomide—leprosy	0.000787	0.0029	CcSEcCtD
Allopurinol—Visual impairment—Thalidomide—leprosy	0.000774	0.00285	CcSEcCtD
Allopurinol—Erythema multiforme—Thalidomide—leprosy	0.000759	0.0028	CcSEcCtD
Allopurinol—Eye disorder—Thalidomide—leprosy	0.00075	0.00276	CcSEcCtD
Allopurinol—Tinnitus—Thalidomide—leprosy	0.000749	0.00276	CcSEcCtD
Allopurinol—Cardiac disorder—Thalidomide—leprosy	0.000745	0.00274	CcSEcCtD
Allopurinol—Immune system disorder—Thalidomide—leprosy	0.000725	0.00267	CcSEcCtD
Allopurinol—Chills—Thalidomide—leprosy	0.000721	0.00265	CcSEcCtD
Allopurinol—Alopecia—Thalidomide—leprosy	0.00071	0.00261	CcSEcCtD
Allopurinol—Vomiting—Dapsone—leprosy	0.000709	0.00261	CcSEcCtD
Allopurinol—Mental disorder—Thalidomide—leprosy	0.000704	0.00259	CcSEcCtD
Allopurinol—Malnutrition—Thalidomide—leprosy	0.000699	0.00257	CcSEcCtD
Allopurinol—Headache—Dapsone—leprosy	0.000698	0.00257	CcSEcCtD
Allopurinol—Flatulence—Thalidomide—leprosy	0.000689	0.00254	CcSEcCtD
Allopurinol—Dysgeusia—Thalidomide—leprosy	0.000685	0.00252	CcSEcCtD
Allopurinol—Nausea—Dapsone—leprosy	0.000662	0.00244	CcSEcCtD
Allopurinol—Tremor—Thalidomide—leprosy	0.000655	0.00241	CcSEcCtD
Allopurinol—Ill-defined disorder—Thalidomide—leprosy	0.000649	0.00239	CcSEcCtD
Allopurinol—Anaemia—Thalidomide—leprosy	0.000646	0.00238	CcSEcCtD
Allopurinol—Agitation—Thalidomide—leprosy	0.000642	0.00237	CcSEcCtD
Allopurinol—Angioedema—Thalidomide—leprosy	0.000639	0.00235	CcSEcCtD
Allopurinol—Malaise—Thalidomide—leprosy	0.00063	0.00232	CcSEcCtD
Allopurinol—Vertigo—Thalidomide—leprosy	0.000628	0.00231	CcSEcCtD
Allopurinol—Leukopenia—Thalidomide—leprosy	0.000626	0.0023	CcSEcCtD
Allopurinol—Convulsion—Thalidomide—leprosy	0.000606	0.00223	CcSEcCtD
Allopurinol—Hypertension—Thalidomide—leprosy	0.000604	0.00222	CcSEcCtD
Allopurinol—Arthralgia—Thalidomide—leprosy	0.000595	0.00219	CcSEcCtD
Allopurinol—Myalgia—Thalidomide—leprosy	0.000595	0.00219	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000591	0.00218	CcSEcCtD
Allopurinol—Discomfort—Thalidomide—leprosy	0.000588	0.00217	CcSEcCtD
Allopurinol—Confusional state—Thalidomide—leprosy	0.000575	0.00212	CcSEcCtD
Allopurinol—Oedema—Thalidomide—leprosy	0.00057	0.0021	CcSEcCtD
Allopurinol—Infection—Thalidomide—leprosy	0.000567	0.00209	CcSEcCtD
Allopurinol—Nervous system disorder—Thalidomide—leprosy	0.000559	0.00206	CcSEcCtD
Allopurinol—Thrombocytopenia—Thalidomide—leprosy	0.000559	0.00206	CcSEcCtD
Allopurinol—Skin disorder—Thalidomide—leprosy	0.000554	0.00204	CcSEcCtD
Allopurinol—Hyperhidrosis—Thalidomide—leprosy	0.000552	0.00203	CcSEcCtD
Allopurinol—Anorexia—Thalidomide—leprosy	0.000544	0.002	CcSEcCtD
Allopurinol—Hypotension—Thalidomide—leprosy	0.000533	0.00196	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Thalidomide—leprosy	0.00052	0.00191	CcSEcCtD
Allopurinol—Insomnia—Thalidomide—leprosy	0.000516	0.0019	CcSEcCtD
Allopurinol—Paraesthesia—Thalidomide—leprosy	0.000512	0.00189	CcSEcCtD
Allopurinol—Somnolence—Thalidomide—leprosy	0.000507	0.00187	CcSEcCtD
Allopurinol—Dyspepsia—Thalidomide—leprosy	0.000502	0.00185	CcSEcCtD
Allopurinol—Decreased appetite—Thalidomide—leprosy	0.000496	0.00183	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Thalidomide—leprosy	0.000493	0.00181	CcSEcCtD
Allopurinol—Pain—Thalidomide—leprosy	0.000488	0.0018	CcSEcCtD
Allopurinol—Constipation—Thalidomide—leprosy	0.000488	0.0018	CcSEcCtD
Allopurinol—Feeling abnormal—Thalidomide—leprosy	0.00047	0.00173	CcSEcCtD
Allopurinol—Gastrointestinal pain—Thalidomide—leprosy	0.000467	0.00172	CcSEcCtD
Allopurinol—Urticaria—Thalidomide—leprosy	0.000453	0.00167	CcSEcCtD
Allopurinol—Abdominal pain—Thalidomide—leprosy	0.000451	0.00166	CcSEcCtD
Allopurinol—Body temperature increased—Thalidomide—leprosy	0.000451	0.00166	CcSEcCtD
Allopurinol—Hypersensitivity—Thalidomide—leprosy	0.00042	0.00155	CcSEcCtD
Allopurinol—Asthenia—Thalidomide—leprosy	0.000409	0.00151	CcSEcCtD
Allopurinol—Pruritus—Thalidomide—leprosy	0.000404	0.00149	CcSEcCtD
Allopurinol—Diarrhoea—Thalidomide—leprosy	0.00039	0.00144	CcSEcCtD
Allopurinol—Dizziness—Thalidomide—leprosy	0.000377	0.00139	CcSEcCtD
Allopurinol—Vomiting—Thalidomide—leprosy	0.000363	0.00134	CcSEcCtD
Allopurinol—Rash—Thalidomide—leprosy	0.00036	0.00132	CcSEcCtD
Allopurinol—Dermatitis—Thalidomide—leprosy	0.000359	0.00132	CcSEcCtD
Allopurinol—Headache—Thalidomide—leprosy	0.000357	0.00132	CcSEcCtD
Allopurinol—Nausea—Thalidomide—leprosy	0.000339	0.00125	CcSEcCtD
